Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing ...
As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...
A live webcast of the presentation will be available on the "Events & Presentations" page in the Investors section of the ...
Abu Dhabi successfully completes its first gene therapy for genetic blood disorders, revolutionizing treatment approaches for ...
Abu Dhabi introduces a revolutionary gene therapy for hemoglobinopathies, utilizing CRISPR-Cas9 technology. Explore how this ...
CRISPR/Cas9 gene-editing therapy is a groundbreaking technology that enables highly precise modification of disease-causing ...
The US FDA has greenlit Mitapivat, the first oral treatment for anaemia in adults with thalassemia, marking a significant advancement in thalassemia care.
In a landmark advance for thalassemia care, US FDA has approved Mitapivat, the first oral treatment for anaemia in adults ...
MUSCAT: The decision to mandate premarital medical examinations for all Omanis wishing to get married, as per Royal Decree No 111/2025, represents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback